Risers and fallers: Lamprell, Sports Direct, Summit Therapeutics...
Lamprell shares soared after it secured a US$90mln contract to transform a shipping vessel into floating accommodation for Statoil's workers
Company
Allergy Therapeutics PLC
LON:AGY
Allergy Therapeutics PLC is an international commercial biotechnology company, headquartered in the UK, focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The company sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
298 stories · page 13 of 15
Allergy Therapeutics half yearly revenues grow amid market turmoil
Allergy Therapeutics said the global allergy treatment market had seen some “turmoil” that had affected the competitive market environment in Europe and the US.
Archive
Burberry Group shake-up well-received
Burberry’s surprise boardroom change yesterday gets plaudits from UBS
Archive
Proactive news highlights: FairFX, Allergy Therapeutics, SalvaRx, Akers Biosciences, GW Pharma & more
Low-cost currency provider FairFX enjoyed its best ever week last week thanks to heightened trading activity amid the UK’s EU referendum vote.
Allergy Therapeutics to take different approach to grass pollen jab
The next dose range study is planned to start next year with Allergy waiting until it hears the outcome of what’s called an End of Phase II meeting with the US Food & Drug Administration.
Allergy Therapeutics appoints ex- Skyepharma man as FD
Peter Jensen, Allergy’s chairman said Wykeham’s experience in life sciences was well suited to Allergy.
Proactive news highlights: Allergy Therapeutics, Bushveld, Metal Tiger, Windar and more...
Allergy Therapeutics' latest clinical study "encouraging", Metal Tiger makes new copper discovery in Thailand and Regency Mines to expand into oil and gas.
Imagination Technologies leads shares higher on bid talk
Chinese tech fund buys stake in graphics chip developer
Investments and investor services
Shares shrug off downbeat Chinese data
The Footsie rose 12 points to 6137 while small-cap indices also advanced
Allergy Therapeutics' results not to be sniffed at
The phase II trial assessed the response from 371 patients, which revealed a statistically significant dose-response relationship from the groups receiving the medication.
NetScientific PLC unveils Ian Postlethwaite as new CFO
We knew Postlethwaite was leaving Allergy Therapeutics after 14 years; now we know where he is going to
Archive
Proactive news summary: Allergy Therapeutics PLC, Eurasia Mining PLC, Metal Tiger PLC and more...
Sirius Minerals' "world class" North Yorkshire project, update on Aureus and Allergy Therapeutics to lose finance director.
Allergy Therapeutics PLC FD off to new pastures
“Ian leaves the company in the strongest position it has ever been in, in terms of sales, cash balance and growth potential...”
Investments and investor services
Admiral Group Plc boosted by big Nomura upgrade
Admiral Group Plc, RSA Insurance Group Plc, Barclays Plc, Meggit Plc, Genel Energy Plc and Fastjet Plc were all in Tuesday’s broker spotlight.
Investments and investor services
Westminster Group PLC provides a highlight on busy Tuesday for small caps
Westminster Group PLC, Forbidden Technologies PLC, KEFI Minerals PLC, Ten Alps, Sierra Rutile Ltd, RapidCloud International PLC, Allergy Therapeutics PLC, Regenersis PLC, Eckoh PLC, and Gulf Keystone Petroleum Limited were among Tuesday’s s
Allergy Therapeutics PLC outperforming the market
Not to be sneezed at: Allergy Therapeutics' ground-breaking allergy vaccines address several lucrative markets
Risers & fallers, including Westminster Group PLC, Kefi Minerals PLC and Ten Alps PLC
Kolar Gold and Zanaga don't know why their share prices are going up, meanwhile, for Tuesday's biggest AIM faller Messaging International it was all too clear ...
Allergy Therapeutics PLC grows in Europe and targets US
Revenue in the six months to December 31 rose 12% to £31.5mln
Forbidden Technologies plc set for Tuesday showcase
Forbidden’s final results will follow optimistic interims, released in September, which highlighted a re-focussing on sports and its consumer video editing platform eva.
Week Ahead: Argos owner could bow out on a low
Other big names reporting this week include the Pru, G4S and Paddy Power Betfair. Among small caps, updates from Telit, Forbidden Technologies and StatPro catch they eye